• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型半合成广谱抗生素阿洛西林的药代动力学(作者译)

[Pharmacokinetics of azlocillin, a new semisynthetic, wide-spectrum antibiotic (author's transl)].

作者信息

Wirth K, Schomerus M, Hengstmann J H

出版信息

Infection. 1976;4(2):25-30. doi: 10.1007/BF01638344.

DOI:10.1007/BF01638344
PMID:977133
Abstract

Azlocillin, a new semisynthetic penicillin with a wide spectrum of antimicrobial activity and a member of the ureidopenicillin group, was administered to ten adults in a dosage of 2 g by intravenous bolus injection. The determination of antibiotic activity in serum and urine demonstrated an average concentration of 58.9 mug/ml after one hour, 28.1 mug/ml after two hours and 6.1 mug/ml after four hours. The total urinary excretion was 60% within six hours. The pharmacokinetic parameters were calculated for the one and two compartment models, respectively. Mathematical analysis according to an open two-compartment model resulted in better curve adjustment as judged from the sum of the deviant squares. The resulting parameters for volume of distribution and rate of elimination show only minor differences however. Similar results were seen on comparison with the respective data for ampicillin.

摘要

阿洛西林是一种新型半合成青霉素,具有广泛的抗菌活性,属于脲基青霉素类。对10名成年人进行静脉推注,剂量为2克。血清和尿液中抗生素活性的测定表明,1小时后平均浓度为58.9微克/毫升,2小时后为28.1微克/毫升,4小时后为6.1微克/毫升。6小时内尿中总排泄量为60%。分别计算了单室和双室模型的药代动力学参数。根据开放双室模型进行的数学分析表明,从偏差平方和判断,曲线拟合效果更好。然而,分布容积和消除速率的结果参数仅显示出微小差异。与氨苄西林的相应数据相比,结果相似。

相似文献

1
[Pharmacokinetics of azlocillin, a new semisynthetic, wide-spectrum antibiotic (author's transl)].新型半合成广谱抗生素阿洛西林的药代动力学(作者译)
Infection. 1976;4(2):25-30. doi: 10.1007/BF01638344.
2
[Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)].阿洛西林和美洛西林:两种新型半合成酰脲类青霉素(作者译)
Infection. 1977;5(3):163-9. doi: 10.1007/BF01639753.
3
[Azlocillin--a new anti-pseudomonas penicillin. A review of the literature and pharmacokinetic studies].[阿洛西林——一种新型抗假单胞菌青霉素。文献综述与药代动力学研究]
Infection. 1982;10 Suppl 3:S184-90. doi: 10.1007/BF01640668.
4
Pharmacokinetics of temocillin in volunteers.
Drugs. 1985;29 Suppl 5:99-102. doi: 10.2165/00003495-198500295-00020.
5
[Pharmacokinetics of Azlocillin in premature and newborn infants (author's transl)].阿洛西林在早产儿和新生儿中的药代动力学(作者译)
Arzneimittelforschung. 1979;29(12a):1949-51.
6
Pharmacokinetics of azlocillin in healthy subjects.阿洛西林在健康受试者中的药代动力学。
Scand J Infect Dis Suppl. 1981;29:49-54.
7
[Antibacterial spectrum of mezlocillin and azlocillin, two new antibiotics of the ureidopenicillin group (author's transl)].
Med Clin (Barc). 1982 May 1;78(9):363-71.
8
[Bone and blood levels of azlocillin after intra-arterial injection in the dog].[犬动脉内注射阿洛西林后的骨与血药浓度]
Presse Med. 1984 Mar 29;13(13):802-4.
9
[Pharmacokinetic studies on broad spectrum antibiotic combinations of penicillin and oxacillin in normal volunteers (author's transl)].正常志愿者中青霉素与苯唑西林广谱抗生素联合用药的药代动力学研究(作者译)
Arzneimittelforschung. 1979;29(11):1769-804.
10
Clinical pharmacology of a new ureidopenicillin: Bay K 49999.
Chemotherapy. 1980;26(2):81-90. doi: 10.1159/000237887.

引用本文的文献

1
Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.阿洛西林在肾功能正常和受损受试者中的药代动力学。
Antimicrob Agents Chemother. 1980 Mar;17(3):344-9. doi: 10.1128/AAC.17.3.344.
2
[Azlocillin--a new anti-pseudomonas penicillin. A review of the literature and pharmacokinetic studies].[阿洛西林——一种新型抗假单胞菌青霉素。文献综述与药代动力学研究]
Infection. 1982;10 Suppl 3:S184-90. doi: 10.1007/BF01640668.
3
Elimination of azlocillin in patients with biliary t-tube drainage.胆汁T管引流患者中阿洛西林的消除情况。

本文引用的文献

1
Clinical pharmacology of carbenicillin compared with other penicillins.羧苄青霉素与其他青霉素相比的临床药理学。
J Infect Dis. 1970 Sep;122:Suppl:S9-13. doi: 10.1093/infdis/122.supplement_1.s9.
2
Theoretical drug levels during multiple dosing in a two-compartment open model.二室开放模型多次给药期间的理论药物水平。
Arch Int Pharmacodyn Ther. 1971 Oct;193(2):294-303.
3
Drug elimination and apparent volume of distribution in multicompartment systems.多室系统中的药物消除与表观分布容积
Eur J Clin Pharmacol. 1982;22(5):435-9. doi: 10.1007/BF00542549.
4
The pharmacokinetics of furazlocillin in healthy humans.呋苄西林在健康人体中的药代动力学。
J Pharmacokinet Biopharm. 1983 Feb;11(1):5-30. doi: 10.1007/BF01061765.
5
Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.囊性纤维化患者的抗生素药代动力学。差异及临床意义。
Clin Pharmacokinet. 1987 Oct;13(4):228-53. doi: 10.2165/00003088-198713040-00002.
6
Pharmacokinetic comparison of 5 g of azlocillin every 8 h and 4 g every 6 h in healthy volunteers.健康志愿者中每8小时静脉滴注5克阿洛西林与每6小时静脉滴注4克阿洛西林的药代动力学比较。
Antimicrob Agents Chemother. 1989 May;33(5):710-3. doi: 10.1128/AAC.33.5.710.
7
Pharmacokinetics of mezlocillin in healthy volunteers.美洛西林在健康志愿者体内的药代动力学。
Antimicrob Agents Chemother. 1978 Dec;14(6):801-6. doi: 10.1128/AAC.14.6.801.
8
Pharmacokinetics of azlocillin in persons with normal and impaired renal functions.阿洛西林在肾功能正常和受损者中的药代动力学。
Antimicrob Agents Chemother. 1978 Sep;14(3):288-91. doi: 10.1128/AAC.14.3.288.
9
[In vitro activity of mezlocillin, azlocillin and carbenicillin against bacteroidaceae with particular reference to bacteroides fragilis (author's transl)].美洛西林、阿洛西林和羧苄西林对拟杆菌科的体外活性,特别针对脆弱拟杆菌(作者译)
Infection. 1977;5(1):17-21. doi: 10.1007/BF01639104.
10
Comparative study of the binding of acylureidopenicillins and carbenicillin to human serum proteins.酰脲类青霉素和羧苄青霉素与人血清蛋白结合的比较研究。
Infection. 1979;7(3):102-8. doi: 10.1007/BF01641306.
J Pharm Sci. 1972 Jun;61(6):952-4. doi: 10.1002/jps.2600610630.
4
Pharmacokinetic interpretation of penicillin levels in serum and urine after intravenous administration.
Antimicrob Agents Chemother (Bethesda). 1969;9:42-8. doi: 10.1128/AAC.9.1.42.
5
The change in serum, urine and renal tissue levels after administration of various doses of carbenicillin.给予不同剂量羧苄青霉素后血清、尿液及肾组织水平的变化。
Int J Clin Pharmacol. 1972 Nov;6(4):320-3.